Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

OBJECTIVE: Recombinant human leptin (metreleptin) improves glycemia and hypertriglyceridemia in patients with generalized lipodystrophy; antibody development with in vitro neutralizing activity has been reported. We aimed to characterize anti-metreleptin antibody development, including in vitro neut...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Endocrinol (Oxf)
Prif Awduron: Chan, Jean L., Koda, Joy, Heilig, Joseph S., Cochran, Elaine K., Gorden, Phillip, Oral, Elif A., Brown, Rebecca J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4875885/
https://ncbi.nlm.nih.gov/pubmed/26589105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.12980
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg